Market Tracker

07/26 4:35am ET

Vanda Pharmaceuticals Inc (NASDAQ:VNDA)

16.05
Delayed Data
As of Jul 25
 -0.45 / -2.73%
Today’s Change
10.98
Today|||52-Week Range
18.00
+0.63%
Year-to-Date

Today’s Trading

Previous close16.50
Today’s open16.50
Day’s range15.95 - 16.73
Volume521,153
Average volume (3 months)479,961
Market cap$735.1M
Dividend yield--
Data as of 07/25/2017

Growth & Valuation

Earnings growth (last year)+56.38%
Earnings growth (this year)-1,538.89%
Earnings growth (next 5 years)+19.10%
Revenue growth (last year)+32.83%
P/E ratioNM
Price/Sales4.75
Price/Book5.53

Competitors

 Today’s
change
Today’s
% change
HSKAHeska Corp+0.22+0.21%
RVNCRevance Therapeutics...-0.35-1.45%
ENTAEnanta Pharmaceutica...-0.04-0.11%
CYTKCytokinetics Inc-0.05-0.35%
Data as of 07/25/2017

Financials

Next reporting dateAugust 2, 2017
EPS forecast (this quarter)-$0.19
Annual revenue (last year)$146.0M
Annual profit (last year)-$18.0M
Net profit margin-12.33%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mihael Hristos Polymeropoulos
Chief Financial Officer, Treasurer &
Senior VP
James Patrick Kelly
Corporate headquarters
Washington, District Of Columbia

Forecasts